Answer to Mungmunpuntipantip et al. "SARS CoV-2 vaccine AND rituximab" Joint Bone Spine 2021;88:105281

Joint Bone Spine. 2022 Jan;89(1):105283. doi: 10.1016/j.jbspin.2021.105283. Epub 2021 Oct 1.

¹ Department of Rheumatology, CHRU de Besançon, 3, boulevard Fleming, 25000 Besançon, France; EA 4267 "PEPITE", UFR Santé, Franche-Comté University, 19, rue Ambroise Paré, bâtiment S, 25030 Besançon cedex, France. Electronic address: [email protected].
² Virology laboratory, CHRU de Besançon, 3, boulevard Fleming, 25000 Besançon, France.
³ Department of Rheumatology, CHRU de Besançon, 3, boulevard Fleming, 25000 Besançon, France.
⁴ Department of Rheumatology, CHRU de Besançon, 3, boulevard Fleming, 25000 Besançon, France; EA 4267 "PEPITE", UFR Santé, Franche-Comté University, 19, rue Ambroise Paré, bâtiment S, 25030 Besançon cedex, France.
⁵ Department of Rheumatology, CHRU de Besançon, 3, boulevard Fleming, 25000 Besançon, France; EA 4266 « EPILAB », UFR Santé, Franche-Comté University, 19, rue Ambroise Paré, bâtiment S, 25030 Besançon cedex, France.

No abstract available

Keywords: COVID; Rituximab; Vaccine.

Publication types